Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076707767> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W2076707767 abstract "The standard treatment of Cushing disease is surgery. Radiotherapy and steroïdogenesis inhibitors are second-line treatments. The new multi-ligand somatostatin analogs, such as SOM230, having a much higher affinity with several receptors of somatostatin (SSTR1,3, and 5) than octreotid (mostly a SSTR2 receptor) have been synthetized. Some studies have shown that SSTR5 is predominantly expressed in corticotroph pituitary adenomas and that SOM230 has more efficacy than octreotid in the treatment of Cushing disease. It has been suggested that the thiazolinidinediones, PPAR-gamma agonists, might also be useful in the treatment of this disease, but studies are still limited and give conflicting results. In a recent study conducted on dogs, Castillo et al have shown that the retinoïds give encouraging results and might open a new pathway in the treatment of Cushing disease. But further studies, especially on humans, are necessary before conclusions can be reached. Labeur and his team have contributed a study on the use of gamma-interferon on murine pituitary cells and on human and murine corticotroph pituitary adenoma cells, and they have evidenced a 20 to 60% decrease in the production of ACTH in 5 cases out of 7 in the tumoral cells treated--versus the non-treated ones. Eventually, Pivonello and his team have confirmed the D2 dopaminergic receptor expression in corticotroph pituitary cells, mainly in the intermediary zone. Thus they have suggested that the dopaminergic agonists--such as cabergoline-could be used in corticotroph pituitary adenomas derivated from the intermediary zone." @default.
- W2076707767 created "2016-06-24" @default.
- W2076707767 creator A5014016072 @default.
- W2076707767 creator A5074308093 @default.
- W2076707767 date "2007-06-01" @default.
- W2076707767 modified "2023-10-01" @default.
- W2076707767 title "Nouvelles thérapeutiques médicales dans la maladie de Cushing" @default.
- W2076707767 cites W1988641856 @default.
- W2076707767 cites W2002337307 @default.
- W2076707767 cites W2011055073 @default.
- W2076707767 cites W2057835402 @default.
- W2076707767 cites W2059027605 @default.
- W2076707767 cites W2065532093 @default.
- W2076707767 cites W2108087543 @default.
- W2076707767 cites W2116553454 @default.
- W2076707767 cites W2117731187 @default.
- W2076707767 cites W2123601063 @default.
- W2076707767 cites W2159712672 @default.
- W2076707767 cites W2168906621 @default.
- W2076707767 cites W2170825600 @default.
- W2076707767 doi "https://doi.org/10.1016/s0003-4266(07)80005-9" @default.
- W2076707767 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17961656" @default.
- W2076707767 hasPublicationYear "2007" @default.
- W2076707767 type Work @default.
- W2076707767 sameAs 2076707767 @default.
- W2076707767 citedByCount "1" @default.
- W2076707767 crossrefType "journal-article" @default.
- W2076707767 hasAuthorship W2076707767A5014016072 @default.
- W2076707767 hasAuthorship W2076707767A5074308093 @default.
- W2076707767 hasConcept C126322002 @default.
- W2076707767 hasConcept C134018914 @default.
- W2076707767 hasConcept C137183658 @default.
- W2076707767 hasConcept C150008808 @default.
- W2076707767 hasConcept C170493617 @default.
- W2076707767 hasConcept C2776297358 @default.
- W2076707767 hasConcept C2776810848 @default.
- W2076707767 hasConcept C2777433750 @default.
- W2076707767 hasConcept C2777658017 @default.
- W2076707767 hasConcept C2779064019 @default.
- W2076707767 hasConcept C2779134260 @default.
- W2076707767 hasConcept C2779371878 @default.
- W2076707767 hasConcept C2779832395 @default.
- W2076707767 hasConcept C2984496839 @default.
- W2076707767 hasConcept C513476851 @default.
- W2076707767 hasConcept C71315377 @default.
- W2076707767 hasConcept C71924100 @default.
- W2076707767 hasConcept C79381400 @default.
- W2076707767 hasConcept C80115893 @default.
- W2076707767 hasConceptScore W2076707767C126322002 @default.
- W2076707767 hasConceptScore W2076707767C134018914 @default.
- W2076707767 hasConceptScore W2076707767C137183658 @default.
- W2076707767 hasConceptScore W2076707767C150008808 @default.
- W2076707767 hasConceptScore W2076707767C170493617 @default.
- W2076707767 hasConceptScore W2076707767C2776297358 @default.
- W2076707767 hasConceptScore W2076707767C2776810848 @default.
- W2076707767 hasConceptScore W2076707767C2777433750 @default.
- W2076707767 hasConceptScore W2076707767C2777658017 @default.
- W2076707767 hasConceptScore W2076707767C2779064019 @default.
- W2076707767 hasConceptScore W2076707767C2779134260 @default.
- W2076707767 hasConceptScore W2076707767C2779371878 @default.
- W2076707767 hasConceptScore W2076707767C2779832395 @default.
- W2076707767 hasConceptScore W2076707767C2984496839 @default.
- W2076707767 hasConceptScore W2076707767C513476851 @default.
- W2076707767 hasConceptScore W2076707767C71315377 @default.
- W2076707767 hasConceptScore W2076707767C71924100 @default.
- W2076707767 hasConceptScore W2076707767C79381400 @default.
- W2076707767 hasConceptScore W2076707767C80115893 @default.
- W2076707767 hasLocation W20767077671 @default.
- W2076707767 hasLocation W20767077672 @default.
- W2076707767 hasOpenAccess W2076707767 @default.
- W2076707767 hasPrimaryLocation W20767077671 @default.
- W2076707767 hasRelatedWork W2004841229 @default.
- W2076707767 hasRelatedWork W2061702213 @default.
- W2076707767 hasRelatedWork W2069295740 @default.
- W2076707767 hasRelatedWork W2076707767 @default.
- W2076707767 hasRelatedWork W2107173303 @default.
- W2076707767 hasRelatedWork W2131076971 @default.
- W2076707767 hasRelatedWork W2902584871 @default.
- W2076707767 hasRelatedWork W3028940269 @default.
- W2076707767 hasRelatedWork W3086304659 @default.
- W2076707767 hasRelatedWork W4281685298 @default.
- W2076707767 isParatext "false" @default.
- W2076707767 isRetracted "false" @default.
- W2076707767 magId "2076707767" @default.
- W2076707767 workType "article" @default.